Skip to the page

Data / Drug companies / Stallergenes

Stallergenes: 5 products in the FDA NDC directory, labeler code 59617

Stallergenes (labeler code 59617) lists 5 products in the FDA National Drug Code Directory. By type: 5 standardized allergenic extracts. Its main marketing category is biologics (BLA). The newest product started marketing on April 30, 2014.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
59617
Products in commercial distribution
5
Packages
6
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
April 30, 2014
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Biologics (BLA)5100%

Products by type

TypeProductsShare
Standardized allergenic extracts5100%

Dosage forms

Dosage formProductsShare
Tablet, orally disintegrating360%
Kit240%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Oralair59617-0025KitBiologics (BLA)April 30, 2014
Oralair59617-0020KitBiologics (BLA)April 30, 2014
Oralair 300 IR59617-0016Tablet, orally disintegratingBiologics (BLA)April 30, 2014
Oralair 300 IR59617-0015Tablet, orally disintegratingBiologics (BLA)April 30, 2014
Oralair 100 IR59617-0010Tablet, orally disintegratingBiologics (BLA)April 30, 2014

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.